Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 12, 2005, Pages 6454-6459

  Couillard, Charles ^a,b   Ruel, Guillaume ^a   Archer, W Roodly ^a   Pomerleau, Sonia ^a   Bergeron, Jean ^b   Couture, Patrick ^a,b   Lamarche, Benoit ^a,b   Bergeron, Nathalie ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM LESION; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ABDOMINAL FAT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; HYPERINSULINISM; INFLAMMATION; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 28744458485     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2004-2438     Document Type: Article

References (48)

1. 2005 Heart disease and stroke statistics - 2005 update. Dallas: American Heart Association
2. Ross R 1999 Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
3. Gaziano JM, Manson JE, Buring JE, HennekensCH1992 Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 669:249-258
4. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL 1989 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
5. Cooke JP 2000 The endothelium: a new target for therapy. Vasc Med 5:49-53
6. Springer TA 1994 Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314
7. Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferriere F, Attali JR, Gattegno L 1998 Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 21:1008-1013
8. Bannan S, Mansfield MW, Grant PJ 1998 Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 41:460-466
9. Ceriello A, Falleti E, Motz E, Taboga C, Tonutti L, Ezsol Z, Gonano F, Bartoli E 1998 Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 30:146-149
10. Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C, Paroni R, Esposito K, GiuglianoD2004 Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 150:195-200
11. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA 2002 Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 161:233-242
12. Meydani M 2000 Omega-3 fatty acids alter soluble markers of endothelial function in coronary heart disease patients. Nutr Rev 58:56-59
13. Després JP, Lemieux S, Lamarche B, Prud'homme D, Moorjani S, Brun LD, Gagné C, Lupien PJ 1995 The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes 19(Suppl 1):S76-S86
14. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Després JP 2000 Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102:179-184
15. de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF 1991 Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306
16. Lohman TG, Roche AF, Martorell R 1988 The Airlie (VA) consensus conference. In: Lohman TG, Roche AF, Martorell R, eds. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Publishers; 39-80
17. Després JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C 1991 Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 54:471-477
18. Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun D, Gagné C, Giguère M, Bélanger A 1987 Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36:244-250
19. Burstein M, Scholnick HR, Morfin R 1970 Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595
20. St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Després JP, Lamarche B 2001 Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104:2295-2299
21. Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Despres JP, Lamarche B 2001 Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 161:2474-2480
22. Raabo E, Terkildsen TC 1960 On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 12:402-407
23. Morgan CR, Lazarow A 1963 Immunoassay of insulin - two antibody system. Plasma insulin levels in normal, subdiabetic rats. Diabetes 12:115-126
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
25. 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
26. Després JP 2001 Health consequences of visceral obesity. Ann Med 33:534-541
27. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, Bergeron J, Després JP 2001 Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21:961-967
28. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB 2004 The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53:1068-1073
29. Lteif AA, Han K, Mather KJ 2005 Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in Whites and Blacks. Circulation 112:32-38
30. Moller P, Wallin H, Knudsen LE 1996 Oxidative stress associated with exercise, psychological stress and life-style factors. Chem Biol Interact 102:17-36
31. Catapano AL, Maggi FM, Tragni E 2000 Low density lipoprotein oxidation, antioxidants, and atherosclerosis. Curr Opin Cardiol 15:355-363
32. Ruhe RC, McDonald RB 2001 Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20:363S-369S
33. Ursini F, Zamburlini A, Cazzolato G, Maiorino M, Bon GB, Sevanian A 1998 Postprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis. Free Radic Biol Med 25:250-252
34. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y 2003 Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673-4676
35. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C 2002 Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288:2008-2014
36. Després JP, Ferland M, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Thériault G, Bouchard C 1989 Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 9:485-492
37. Després JP, Moorjani S, Tremblay A, Ferland M, Lupien PJ, Nadeau A, Bouchard C 1989 Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women. Clin Invest Med 12:374-380
38. Després JP 1991 Obesity and lipid metabolism: Relevance of body fat distribution. Curr Opin Lipidol 2:5-15
39. Chapman MJ, Guerin M, Bruckert E 1998 Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur Heart J 19(Suppl A):A24-A30
40. Tribble DL, van den Berg JJ, Motchnik PA, Ames BN, Lewis DM, Chait A, Krauss RM 1994 Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content. Proc Natl Acad Sci USA 91:1183-1187
41. Brown AJ, Jessup W 1999 Oxysterols and atherosclerosis. Atherosclerosis 142:1-28
42. Dejager S, Bruckert E, Chapman MJ 1993 Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 34:295-308
43. Tribble DL, Holl LG, Wood PD, Krauss RM 1992 Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189-199
44. Chen NG, Azhar S, Abbasi F, Carantoni M, ReavenGM2000 The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers. Atherosclerosis 152:203-208
45. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, Bosello O, Lechi A 1999 Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes 23:936-942
46. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A 1999 Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 22:1865-1870
47. Ridker PM, Haughie P 1998 Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 46:391-395
48. Ridker PM, Hennekens CH, Buring JE, Rifai N 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843